CX Stock Analysis: Cemex SAB de CV | NYSE
Building Materials | NYSE, USA | Market Cap: 13.838m USD | 12M Return: 5.8% | US1512908898 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 65.6M
EPS Trend: 72.6%
Qual. Beats: 0
Rev. Trend: -32.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cemex is a Mexico-based global producer of cement, ready-mix concrete, aggregates, and related construction materials, headquartered in San Pedro Garza García. Founded in 1906 and listed on the NYSE in 1999, the company sells a wide range of cement grades, specialty concrete mixes, crushed stone and sand products, and urbanization and waste-management solutions, including its low-carbon Vertua line.
The company operates in the Materials sector, specifically Construction Materials. Cement and aggregates are high-volume, low-margin products, so proximity of production facilities to end markets is a key competitive factor in the industry, and demand is closely tied to housing, commercial, and infrastructure construction cycles.
- US infrastructure spending lifts cement volumes and pricing
- Energy costs pressure cement margins amid volatile input prices
- Mexico construction demand and peso swings drive reported results
| Net Income: 485.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.07 > 1.0 |
| NWC/Revenue: -2.90% < 20% (prev -6.01%; Δ 3.11% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.76b > Net Income 485.2m |
| Net Debt (7.26b) to EBITDA (3.56b): 2.04 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (145.9m) vs 12m ago -89.94% < -2% |
| Gross Margin: 32.23% > 18% (prev 31.85%; Δ 0.38% > 0.5%) |
| Asset Turnover: 59.65% > 50% (prev 54.18%; Δ 5.47% > 0%) |
| Interest Coverage Ratio: 3.07 > 6 (EBIT TTM 1.43b / Interest Expense TTM 467.2m) |
| A: -0.02 (Total Current Assets 5.88b - Total Current Liabilities 6.37b) / Total Assets 28.3b |
| B: 0.23 (Retained Earnings 6.47b / Total Assets 28.3b) |
| C: 0.05 (EBIT TTM 1.43b / Avg Total Assets 28.5b) |
| D: 0.81 (Book Value of Equity 12.5b / Total Liabilities 15.4b) |
| Altman-Z'' = 1.82 = BBB |
| DSRI: 1.02 (Receivables 2.96b/2.66b, Revenue 17.0b/15.6b) |
| GMI: 0.99 (GM 31.85% / 32.23%) |
| AQI: 0.96 (AQ_t 0.37 / AQ_t-1 0.39) |
| SGI: 1.09 (Revenue 17.0b / 15.6b) |
| TATA: -0.08 (NI 485.2m - CFO 2.76b) / TA 28.3b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 11, 2026, the stock is trading at USD 9.56 with a total of 4,012,580 shares traded. Over the past week, the price has changed by +0.31%, over one month by -11.63%, over three months by -22.49% and over the past year by +5.82%.
Current recommended Stop Loss: 9.10 (which is 4.8% or 1.6 ATR below the current price).
Cemex SAB de CV has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CX.
- StrongBuy: 4
- Buy: 7
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.8 | 54.9% |
P/E Trailing = 79.9167
P/E Forward = 10.7296
P/S = 0.8122
P/B = 1.124
P/EG = 0.1074
Revenue TTM = 17.0b USD
EBIT TTM = 1.43b USD
EBITDA TTM = 3.56b USD
Long Term Debt = 785.5m USD (from longTermDebt, last quarter)
Short Term Debt = 438.4m USD (from shortTermDebt, last quarter)
Debt = 7.92b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.04b
Net Debt = 7.26b USD (calculated: Debt 7.92b - CCE 653.7m)
Enterprise Value = 21.1b USD (13.8b + Debt 7.92b - CCE 653.7m)
Interest Coverage Ratio = 3.07 (Ebit TTM 1.43b / Interest Expense TTM 467.2m)
EV/FCF = 11.63x (Enterprise Value 21.1b / FCF TTM 1.81b)
FCF Yield = 8.60% (FCF TTM 1.81b / Enterprise Value 21.1b)
FCF Margin = 10.66% (FCF TTM 1.81b / Revenue TTM 17.0b)
Net Margin = 2.85% (Net Income TTM 485.2m / Revenue TTM 17.0b)
Gross Margin = 32.23% ((Revenue TTM 17.0b - Cost of Revenue TTM 11.5b) / Revenue TTM)
Gross Margin QoQ = 35.22% (prev 32.85%)
Tobins Q-Ratio = 0.75 (Enterprise Value 21.1b / Total Assets 28.3b)
Interest Expense / Debt = 5.90% (Interest Expense 467.2m / Debt 7.92b)
Taxrate = 46.40% (468.3m / 1.01b)
NOPAT = 767.8m (EBIT 1.43b * (1 - 46.40%))
Current Ratio = 0.92 (Total Current Assets 5.88b / Total Current Liabilities 6.37b)
Debt / Equity = 0.63 (Debt 7.92b / totalStockholderEquity, last quarter 12.5b)
Debt / EBITDA = 2.04 (Net Debt 7.26b / EBITDA 3.56b)
Debt / FCF = 4.00 (Net Debt 7.26b / FCF TTM 1.81b)
Total Stockholder Equity = 13.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.70% (Net Income 485.2m / Total Assets 28.3b)
RoE = 3.69% (Net Income TTM 485.2m / Total Stockholder Equity 13.1b)
RoCE = 10.28% (EBIT 1.43b / Capital Employed (Equity 13.1b + L.T.Debt 785.5m))
RoIC = 3.54% (NOPAT 767.8m / Invested Capital 21.7b)
WACC = 7.61% (E(13.8b)/V(21.8b) * Re(10.16%) + D(7.92b)/V(21.8b) * Rd(5.90%) * (1-Tc(0.46)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -51.92 | Cagr: -64.46%
[DCF] Terminal Value 77.97% ; FCFF base≈1.36b ; Y1≈1.56b ; Y5≈2.29b
[DCF] Fair Price = 18.89 (EV 34.5b - Net Debt 7.26b = Equity 27.3b / Shares 1.44b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 72.63 | EPS CAGR: 22.40% | SUE: -0.36 | # QB: 0
Revenue Correlation: -32.02 | Revenue CAGR: -1.03% | SUE: 0.50 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.21 | Chg30d=+5.00% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=0.80 | Chg30d=-2.92% | Revisions=+40% | GrowthEPS=+54.4% | GrowthRev=+8.0%
EPS next Year (2027-12-31): EPS=0.91 | Chg30d=-1.63% | Revisions=+40% | GrowthEPS=+12.7% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +62% (up=5, down=0)